Buyers Seek $97M Fees From $335M Drug Price-Fixing Deals
By Ryan Harroff · September 24, 2024, 8:39 PM EDT
A class of direct purchaser plaintiffs in the multidistrict antitrust litigation over generic drug pricing asked a Pennsylvania federal judge Monday to award them $97 million in fees across six settlements...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login